about us
Dedicated to revolutionizing new drug discovery and development
Overview
LigaChem Biosciences, Inc. (LCB) is a clinical stage biopharmaceutical company dedicated to the discovery and development of innovative medicines by leveraging our medicinal chemistry expertise to make conventional biologics more targeted and potent for the benefit of patients with diseases of highly unmet medical needs. We are advancing sustainable pipelines in therapeutic areas within antibiotics, anti-fibrotics, oncology, and antibody-drug conjugate (ADC) platform technology.
Leveraging
Chemistry for
Better
therapeutics
Chemistry for
Better
therapeutics
Global Team of Scientific Excellence
- Highly experienced management team with over forty years of industry experience in drug discovery, development and commercialization
- Proprietary ADC technology with proven track records of global licensing to industry leading pharmaceuticals and awarded the Best ADC Technology Award
Linking
Chemistry with
Biologics
Chemistry with
Biologics
Growing Revenue Stream with Robust Drug Pipeline
- Continued addition of new pipeline with differentiated advantages using LCB's proprietary platform technology
- Sustainable revenue stream through multiple licensing deals
- Value inflection through clinical development of LCB's own pipelines
- Implementation of strategy to drive mid- and long-term growth engine beyond antibody-drug conjugate monotherapies
Linking
Chemistry with
Biologics
Chemistry with
Biologics